The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 3 Experts Discuss Bone Health

3 Experts Discuss Bone Health

February 18, 2018 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Tridsanu Thopet / SHUTTERSTOCK.COM

Tridsanu Thopet / SHUTTERSTOCK.COM

SAN DIEGO—At the 2017 ACR/ARHP Annual Meeting Nov. 3–8, experts discussed improving bone health in the U.S., gave tips on bone health disorders in pediatrics and reviewed new translational science findings for joint conservation in early osteonecrosis.

You Might Also Like
  • Experts Discuss the Latest Precision Medicine Research
  • Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium
  • The ACR’s State-of-the-Art Clinical Symposium: Experts Discuss Jakinibs, Osteoarthritis, Membranous Lupus Nephritis
Explore This Issue
February 2018
Also By This Author
  • The ACR’s State-of-the-Art Clinical Symposium: Stem Cell Therapy in Autoimmune Disease Evolution, Insights

E. Michael Lewiecki, MD, director of the New Mexico Clinical Research & Osteoporosis Center in Albuquerque, N.M., called on physicians to help improve osteoporosis care, which has declined over the past several years due factors that include fear of drug side effects, dual X-ray absorptiometry (DXA) reimbursement declines and competing guidelines.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

After more than 10 years of dropping hip fracture rates, the rate has plateaued over the past several years, leading to a sizable gap between the actual and projected numbers of 14,000 additional hip fractures and 2,800 additional deaths that could be attributed to fractures, all of which might have been prevented, Dr. Lewiecki said.

“This is why it’s now called a crisis,” he said. “My big audacious goal is to reduce the osteoporosis treatment gap from 80% to 20% in the next 10 years. I’d like to deputize each of you in this audience. I’d like to empower you to do something about this. And you can. There are things that we can all do to help.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Specifically, Dr. Lewiecki said physicians can:

  • Develop a fracture liaison service (FLS) system that identifies those at risk of secondary fracture and delivers the treatment they need. This typically involves an FLS coordinator (often a nurse practitioner or physician’s assistant) who uses software to track patients;
  • Improve DXA reimbursement and employ DXA best practices. “Poor DXA reimbursement leads to poor DXA quality,” he said, urging physicians to work to promote better reimbursement. He also called on physicians to bone up on best practices, with up-to-date DXA training, certification and possibly facility accreditation;
  • Treat to target. An American Society for Bone and Mineral Research-National Osteoporosis Foundation task force suggests treating to a target T score of -2.0, rather than -2.5, could increase confidence “considering the measurement error with the DXA test”; and
  • Knowledge-share through Project ECHO, which involves case-based discussions and brief didactic presentations via videoconference. The project now sports 139 hubs in 23 countries, covering more than 45 diseases, Dr. Lewiecki said.

Catherine Gordon, MD, MS, director of adolescent and transition medicine at Cincinnati Children’s Hospital in Cincinnati, discussed how to treat and manage pediatric patients with bone disorders, from primary osteogenesis imperfecta to secondary bone disorders, including juvenile idiopathic arthritis (JIA), glucocorticoid-induced osteoporosis and anorexia nervosa (AN).

Pages: 1 2 3 | Single Page

Filed Under: Meeting Reports, Osteoarthritis Tagged With: ACR/ARHP Annual Meeting, bone and joint, Juvenile arthritis, Osteoarthritis, OsteonecrosisIssue: February 2018

You Might Also Like:
  • Experts Discuss the Latest Precision Medicine Research
  • Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium
  • The ACR’s State-of-the-Art Clinical Symposium: Experts Discuss Jakinibs, Osteoarthritis, Membranous Lupus Nephritis
  • Osteoporosis Experts Discuss Bisphosphonates, Chronic Kidney Disease

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.